NYSDA Publications

CDC Issues Report on Safety Monitoring of Pfizer COVID-19 Vaccine Booster Doses Among Persons Aged 5-11 Years

The Centers for Disease Control and Prevention (CDC) has issued, as part of its latest Morbidity and Mortality Weekly Report (MMWR), a report on safety monitoring of Pfizer novel coronavirus (COVID-19) vaccine booster doses among persons 5-11 years of age.  CDC notes that among children aged 5–11 years, serious adverse events after dose 3 of the Pfizer COVID-19 vaccine are rare.  To read the CDC report on safety monitoring of Pfizer COVID-19 vaccine booster doses among persons 5-11 years of age, use the first link below.  To access the complete latest CDC MMWR, use the second link below.
https://www.cdc.gov/mmwr/volumes/71/wr/mm7133a3.htm?s_cid=mm7133a3_e&ACSTrackingID=USCDC_921-DM88143&ACSTrackingLabel=A%2FB%20test%20on%20subject%20(CDC)&deliveryName=USCDC_921-DM88143  (CDC report on safety monitoring of Pfizer COVID-19 vaccine booster doses among persons 5-11 years of age)
https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7133-H.pdf?ACSTrackingID=USCDC_921-DM88143&ACSTrackingLabel=A%2FB%20test%20on%20subject%20(CDC)&deliveryName=USCDC_921-DM88143  (CDC complete MMWR)
22380292641